Skip to Main Content

Paper Details

The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
J Neurooncol
1
2023
Author NameAffiliation
Hartmut VatterUniversity Hospital Bonn
Theophilos TzaridisDivision of Clinical Neurooncology, University Hospital Bonn
  • 1 - 2

Datasets

Release 1.2